ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,287Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 122

$351K Total Retail Price of All Prescriptions

Rank: 36 out of 122

358 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Vermont
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 358 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

5% of this provider’s 358 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 6,796 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Vermont
SIMVASTATIN 389 363 1 1
LISINOPRIL 386 368 2 2
FUROSEMIDE 272 255 3 5
METOPROLOL SUCCINATE 263 231 4 11
LEVOTHYROXINE SODIUM 233 231 5 4
HYDROCHLOROTHIAZIDE 214 194 6 6
OMEPRAZOLE 168 156 7 3
AMLODIPINE BESYLATE 164 154 8 7
METFORMIN HCL 158 156 9 14
METOPROLOL TARTRATE 145 139 10 8
WARFARIN SODIUM 139 139 11 9
CHLORTHALIDONE 125 114 12 71
SERTRALINE HCL 123 123 13 18
ATENOLOL 121 121 14 10
ALLOPURINOL 117 112 15 33
GABAPENTIN 99 72 16 12
RANITIDINE HCL 97 88 17 39
TRAZODONE HCL 91 91 18 21
ATORVASTATIN CALCIUM 84 78 19 13
PANTOPRAZOLE SODIUM 84 68 19 23
POTASSIUM CHLORIDE 77 77 21 22
HYDROCODONE-ACETAMINOPHEN 75 61 S3 22 16
PREDNISONE 73 71 23 24
CITALOPRAM HBR 72 71 24 15
CARBIDOPA-LEVODOPA 69 69 25 79
FLUOXETINE HCL 67 55 26 38
ALENDRONATE SODIUM 65 65 27 35
KLOR-CON M20 63 59 28 67
NEXIUM 63 63 28 32
QUETIAPINE FUMARATE 61 61 30 46
GLIPIZIDE XL 59 54 31 106
DONEPEZIL HCL 56 56 32 25
TAMSULOSIN HCL 56 56 32 26
LOSARTAN POTASSIUM 56 56 32 17
AZITHROMYCIN 52 50 35 53
ISOSORBIDE MONONITRATE ER 50 50 36 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 1, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.